ArticleFeaturedEfferocytosis in cancer: when "clean-up" cells help tumours hide
Efferocytosis — the tidy disposal of dying cells — keeps healthy tissue calm. But tumours hijack the same process to dampen immunity and grow unchecked.
Medical writer & science communicator
I help turn complex biomedical research into clear, evidence-based stories that people can trust and act on.
Based in Toronto. Working with clients in Canada and the US.
Biotech
Investors, partners & scientific teams
Health-tech
Product, clinical & marketing teams
Curious readers
Scientifically literate, non-specialist audiences
Worked with
Services
One-off projects or monthly retainers. Every project starts with a free discovery call.
Long-form scientific narratives for business audiences, investors, partners, clinicians, and prospects. Built from primary literature, framed for the decision the reader is trying to make.
Peer-reviewed writing for academic, clinical, and industry audiences. I support the process from literature search and evidence synthesis to structure, editing, formatting, and journal submission.
Investor, scientific, grant-review, and patient-facing presentations that turn complex evidence into a clear visual story. Story arc first, slides second, so the deck is easier to follow, present, and remember.
Single-page visual explainers for social, web, and patient education, built to hold up to a scientist's eye and a non-scientist's attention span. Designed to make mechanisms, evidence, and health concepts clearer without flattening the science.
Long-form blogs and ongoing series for scientifically literate readers who want clarity without oversimplification. I write with the evidence in view, but with enough story to make people keep reading.
Evidence-based content plans for biotech and health-tech teams who need a credible voice but do not yet have an in-house writer. I help shape topics, angles, cadence, and messaging around the literature your audience already trusts.
ArticleFeaturedEfferocytosis — the tidy disposal of dying cells — keeps healthy tissue calm. But tumours hijack the same process to dampen immunity and grow unchecked.
ArticleFeaturedHow do homing pigeons navigate? A surprising hypothesis points not to a compass in the beak, but to immune-adjacent cells responding to magnetic fields.
Slide deckFeaturedA guest lecture deck introducing the core ideas of tumour immunology — from immune evasion to checkpoint blockade — for an audience of non-specialists.
How I work
We talk about what you're building, who needs to understand it, and where the science currently lives. Papers, internal data, existing drafts, half-formed ideas — all of it is useful. I ask a lot of questions.
You get a short proposal with the deliverables, timeline, and fee. I like things to be clear before the writing starts.
I write the first draft within the agreed timeline, with sources easy to trace. For longer projects, I send updates along the way. I don't like disappearing until the deadline, and I assume you don't either.
Two rounds of revision are included. I read edits carefully. I'll also push back if the science doesn't support a requested change, because that's part of what you're hiring me for.
You get the final files in the format you need, with citations, source lists, and version history if useful.
Curious how I think before you commit to a call? I post on LinkedIn about FDA approvals, biotech news, and the translation problems in science writing. Follow along →
Most projects start as one piece of work. Some become ongoing collaborations. Either works.
Jainu took a dense set of immunology data and turned it into a story our investors actually understood — without losing an ounce of scientific rigour. Rare and invaluable.
Her medical writing is meticulous and clear. Manuscripts she touches come back tighter, better argued, and ready for review.
For our public-health campaign she made cell biology genuinely exciting to a lay audience. The infographics alone drove our best engagement to date.
Have a project in mind, or just want to talk science writing? I'd love to hear from you.
Get in touch